MedImmune
Healthcare, Pharmaceuticals, and Biotech
Company Overview
MedImmune is a US-based biotechnology company that specializes in the development of novel immunotherapies for the prevention and treatment of infectious diseases, cancers, and other serious medical conditions. It was founded in 1988 and later acquired by AstraZeneca in 2007. MedImmune's products and pipeline focus on innovative biologics, including monoclonal antibodies, fusion proteins, and vaccines. Key products include Synagis for the prevention of respiratory syncytial virus (RSV) in infants, FluMist Quadrivalent, a nasal spray flu vaccine, and Imfinzi, an immunotherapy for the treatment of non-small cell lung cancer. The company is headquartered in Gaithersburg, Maryland, and has operations in California, Colorado, and the United Kingdom.
Email Formats
Discover the email patterns used at MedImmune to connect with the right people.
| Email Format | Example | Percentage |
|---|---|---|
| firstname.lastname@company.com | john.doe@company.com | 45% |
| firstname@company.com | john@company.com | 30% |
| firstinitial.lastname@company.com | j.doe@company.com | 15% |
| firstname_lastname@company.com | john_doe@company.com | 10% |
View Email formats of the company.
Email Verification Tool
Get verified email addresses of any IBM employee. Enjoy 100 free lookups every month.